The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support

Authors

  • Delphine Staumont-Sallé
  • Charles Taieb Patient Priority Department, European Market Maintenance Assessment, FR-94120 Fontenay sous Bois, France
  • Stephanie Merhand
  • Jason Shourick

DOI:

https://doi.org/10.2340/actadv.v101.750

Keywords:

atopic dermatitis, Atopic Dermatitis Control Tool, patient centricity

Abstract

The evaluation of global atopic dermatitis control is key to minimizing disease burden. The Atopic Dermatitis Control Tool (ADCT) has been developed for this purpose. Participants (diagnosed by a physician) were recruited to this observational cross-sectional study using real-life methodology and completed a questionnaire on sociodemographic and personal information. The ADCT algorithm, described by Pariser, was used to categorize patients as having controlled or uncontrolled atopic dermatitis. Data were collected for 1,606 patients. Median age of the patients was 40 years , and 1,023 (63.7%) patients were women. A total of 1,146 (71.4%) patients had uncontrolled atopic dermatitis according to the ADCT score. Patients with uncontrolled disease were at significantly higher risk of a high stress level and were more likely to be absent from work than those with controlled disease. In conclusion, a key factor for predicting disease burden in atopic dermatitis is patient self-assessed disease control in terms of multiple dimensions: stress, sleep, quality of life, work absenteeism and loss of productivity.

Downloads

Download data is not yet available.

References

Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol 2017; 137: 18-25.

https://doi.org/10.1016/j.jid.2016.08.022 DOI: https://doi.org/10.1016/j.jid.2016.08.022

Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Knol EF, et al. Serum biomarker profiles suggest that atopic dermatitis is a systemic disease. J Allergy Clin Immunol 2018; 141: 1523-1526.

https://doi.org/10.1016/j.jaci.2017.12.991 DOI: https://doi.org/10.1016/j.jaci.2017.12.991

Oliveira C, Torres T. More than skin deep: the systemic nature of atopic dermatitis. Eur J Dermatol EJD 2019; 29: 250-258.

Bylund S, Kobyletzki L, Svalstedt M, Svensson. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol 2020; 100: adv00160.

https://doi.org/10.2340/00015555-3510 DOI: https://doi.org/10.2340/00015555-3510

Richard M-A, Corgibet F, Beylot-Barry M, Barbaud A, Bodemer C, Chaussade V, et al. Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study. J Eur Acad Dermatol Venereol 2018; 32: 1967-1971.

https://doi.org/10.1111/jdv.14959 DOI: https://doi.org/10.1111/jdv.14959

Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. The Lancet 2020; 396: 345-360.

https://doi.org/10.1016/S0140-6736(20)31286-1 DOI: https://doi.org/10.1016/S0140-6736(20)31286-1

Koszorú K, Borza J, Gulácsi L, Sárdy M. Quality of life in patients with atopic dermatitis. Cutis 2019; 104: 174-177.

Kage P, Simon J, Treudler R. Atopic dermatitis and psychosocial comorbidities. J Dtsch Dermatol Ges 2020; 18: 93-102.

https://doi.org/10.1111/ddg.14029 DOI: https://doi.org/10.1111/ddg.14029

Girolomoni G, Gadkari A, Auziere S, Puig L, Barbarot S, Chosidow O, et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Canada and Europe. Value Health 2017; 20: A807.

https://doi.org/10.1016/j.jval.2017.08.2407 DOI: https://doi.org/10.1016/j.jval.2017.08.2407

Chang Y-S, Chiang B-L. Sleep disorders and atopic dermatitis: a 2-way street? J Allergy Clin Immunol 2018; 142: 1033-1040.

https://doi.org/10.1016/j.jaci.2018.08.005 DOI: https://doi.org/10.1016/j.jaci.2018.08.005

Mann C, Dreher M, Weeß H-G, Staubach P. Sleep disturbance in patients with urticaria and atopic dermatitis: an underestimated burden. Acta Derm Venereol 2020; 100: adv00073.

https://doi.org/10.2340/00015555-3416 DOI: https://doi.org/10.2340/00015555-3416

Lin T-K, Zhong L, Santiago JL. Association between stress and the HPA axis in the atopic dermatitis. Int J Mol Sci 2017; 18: 2131.

https://doi.org/10.3390/ijms18102131 DOI: https://doi.org/10.3390/ijms18102131

Suárez AL, Feramisco JD, Koo J, Steinhoff M. Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol 2012; 92: 7-15.

https://doi.org/10.2340/00015555-1188 DOI: https://doi.org/10.2340/00015555-1188

Chung J, Simpson EL. The socioeconomics of atopic dermatitis. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol 2019; 122: 360-366.

https://doi.org/10.1016/j.anai.2018.12.017 DOI: https://doi.org/10.1016/j.anai.2018.12.017

Ariëns LFM, van Nimwegen KJM, Shams M, de Bruin DT, van der Schaft J, van Os-Medendorp H, et al. Economic burden of adult patients with moderate to severe atopic dermatitis indicated for systemic treatment. Acta Derm Venereol 2019; 99: 762-768.

https://doi.org/10.2340/00015555-3212 DOI: https://doi.org/10.2340/00015555-3212

Stróżek J, Samoliński BK, Kłak A, Gawińska-Drużba E, Izdebski R, Krzych-Fałta E, et al. The indirect costs of allergic diseases. Int J Occup Med Environ Health 2019; 32: 281-290.

https://doi.org/10.13075/ijomeh.1896.01275 DOI: https://doi.org/10.13075/ijomeh.1896.01275

Le PH, Vo TQ. Economic burden and productivity loss related to eczema: a prevalence-based follow-up study in Vietnam. JPMA J Pak Med Assoc 2019; 69: S57-S63.

Simpson E, Eckert L, Gadkari A, Mallya UG, Yang M, Nelson L, et al. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. BMC Dermatol 2019; 19: 15.

https://doi.org/10.1186/s12895-019-0095-3 DOI: https://doi.org/10.1186/s12895-019-0095-3

Pariser DM, Simpson EL, Gadkari A, Bieber T, Margolis DJ, Brown M, et al. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Curr Med Res Opin 2020; 36: 367-376.

https://doi.org/10.1080/03007995.2019.1699516 DOI: https://doi.org/10.1080/03007995.2019.1699516

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.

https://doi.org/10.1111/j.1365-2230.1994.tb01167.x DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x

Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.

https://doi.org/10.1111/j.0022-202X.2005.23621.x DOI: https://doi.org/10.1111/j.0022-202X.2005.23621.x

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385.

https://doi.org/10.2307/2136404 DOI: https://doi.org/10.2307/2136404

Paradis, Bénédicte 2020-03-03) Comparaison du niveau de stress en fonction du profil social et académique des étudiants rennais en première année de licence,/Université de Rennes 1.

Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004; 140: 1513-1519.

https://doi.org/10.1001/archderm.140.12.1513 DOI: https://doi.org/10.1001/archderm.140.12.1513

Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol 2013; 169: 1326-1332.

https://doi.org/10.1111/bjd.12590 DOI: https://doi.org/10.1111/bjd.12590

Institute of Medicine (US) Council on Health Care Technology; Mosteller F, Falotico-Taylor J, editors. Quality of life and technology assessment: monograph of the Council on Health Care Technology. Washington (DC): National Academies Press (US); 1989. 6, Assessing quality of life: measures and utility. [accessed 1 August 2021] Available from: https://www.ncbi.nlm.nih.gov/books/NBK235120/.

Ridd MJ, King AJL, Le Roux E, Waldecker A, Huntley AL. Systematic review of self-management interventions for people with eczema. Br J Dermatol 2017; 177: 719-734.

https://doi.org/10.1111/bjd.15601 DOI: https://doi.org/10.1111/bjd.15601

Glazer AM, Rigel DS. Analysis of trends in geographic distribution of US dermatology workforce density. JAMA Dermatol 2017; 153: 472.

https://doi.org/10.1001/jamadermatol.2016.6032 DOI: https://doi.org/10.1001/jamadermatol.2016.6032

Parcours des patients insuffisants cardiaques sévères, Arrêté Dirnov -2019/13, Agence régionale de santé IDF.

Downloads

Published

2021-12-13

How to Cite

Staumont-Sallé, D., Taieb, C., Merhand, S., & Shourick, J. (2021). The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support. Acta Dermato-Venereologica, 101(12), adv00618. https://doi.org/10.2340/actadv.v101.750